Compound ID | 3196
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Folate synthesis inhibitor. Mycobacterial folic acid synthesis inhibitor |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Description: | Synthetic compound; better tolerated than para-aminosalicylic acid and its sodium salt formulation that cause gastrointestinal irritation |
| Year first mentioned: | 1950 |
| Highest development stage: | Clinical Trial (1952) |
| Development status: | Unknown |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54684690 |
| Citation: | https://www.atsjournals.org/doi/abs/10.1164/art.1952.66.5.619?role=tab |